Publisher
Springer Science and Business Media LLC
Reference95 articles.
1. Bisht D, Sharma D, Sharma D, Singh R, Gupta VK. Recent insights into Mycobacterium tuberculosis through proteomics and implications for the clinic. Expert Rev Proteomics. 2019;16(5):443–56. https://doi.org/10.1080/14789450.2019.1608185.
2. Mehta P, Bothiraja C, Kadam S, Pawar A. Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future. Artif Cells Nanomed Biotechnol. 2018;46(3):791–806. https://doi.org/10.1080/21691401.2018.1513938.
3. Shivangi, Meena LS. A novel approach in treatment of tuberculosis by targeting drugs to infected macrophages using biodegradable nanoparticles. Appl Biochem Biotechnol. 2018. https://doi.org/10.1007/s12010-018-2695-5.
4. WHO. Global Tuberculosis Report. (2019). https://www.who.int/tb/publications/global_report/en/. Last accessed on 3rd February, 2020; 12:46 pm.
5. WHO. UN General Assembly High-Level meeting on ending TB. (2018). https://www.who.int/tb/features_archive/UNGA_HLM_ending_TB/en/. Last accessed on 3rd February, 2020; 15:26 pm.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献